y prime
Malvern
About y prime
Y Prime’s innovative software solutions are bringing a new level of transparency to meet the challenges of today’s increasingly complex and competitive clinical and regulatory environment. Working for industry leaders worldwide, Y Prime harnesses information to help clients effectively plan and manage clinical trials on time and within budget. Presently, software companies are forcing products into a Software as a Service (SaaS) platform, which for clinical research leaves much to be desired in terms of customer support. The Y Prime platform is designed to scale as a SaaS platform but is operated with such high level of interaction that we call it a Software With a Service platform.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $12.5M
- Funding stage: Private Equity
- Last round: Private Equity (Feb 2019)
- Website: y-prime.com
- Phone: 267-620-2000
Industries & Categories
Business Intelligence, Clinical Trials, Consulting, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/y-prime-136607 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.